Cecilia Domínguez Conde
- Research Group Leader, Domínguez Conde Group
Cecilia Domínguez Conde is a Group Leader at the Population & Medical Genomics programme of the Genomics Centre. After training as a pharmacist in the University of Seville, Cecilia went on to do a PhD in Immunology at the Research Centre for Molecular Medicine (CeMM) in Vienna where her work focused on dissecting the genetic cause of molecularly undiagnosed primary immunodeficiencies using exome sequencing. In 2019 Cecilia joined the Teichmann lab at the Wellcome Sanger Institute where her focus has been to dissect the diversity of human immune cell types across lymphoid and non-lymphoid tissues as part of the Human Cell Atlas initiative. Her research group at HT uses cutting-edge genomic technologies to study developmental immunology.
Contact
- Web: Domínguez Conde Group
- Email: cecilia.dominguez@fht.org
- Linkedin: Cecilia Domínguez Conde
Selected publications
Single-cell sequencing
- Cross-tissue immune cell analysis reveals tissue-specific features in humans
- Local and systemic responses to SARS-CoV-2 infection in children and adults
- SARS-CoV-2 infection of the oral cavity and saliva
- A cell atlas of human thymic development defines T cell repertoire formation
Inborn errors of immunity
- Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress
- CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis
- Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
- Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity
Reviews
